ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
41 announcements
Artemis reports strong growth led by Gurgaon's record EBITDA and new Raipur operations. Aggressive expansion plans aim for 2,000 beds within five years despite regulatory drug pricing concerns.
Artemis Medicare filed CARE Ratings' quarterly monitoring report on its Rs.330 crore preferential issue. It reports no deviation, with proceeds used as per the disclosed objects.
Q2 FY27 consolidated revenue INR 31,104 Lacs (+13.2% YoY); adj. EBITDA INR 7,150 Lacs (+22.7%, 23.3% margin); PAT INR 3,110 Lacs (+3.7%). Raipur ramp-up dilutes reported margins.
Artemis Medicare reported Q2 FY27 consolidated revenue up 13.2% and PAT up 3.7% year-on-year. Adjusted EBITDA rose 22.7%, with the Raipur hospital launched in July 2026.
Artemis Medicare Services Ltd reported revenue from operations of ₹311 Cr (+13.2% YoY) and net profit of ₹31.1 Cr (+3.7% YoY) for Q2 FY27.
Artemis Medicare scheduled a board meeting for Oct 30, 2026 to approve Q1 un-audited results. Trading window remains closed until Nov 1, 2026.
Artemis Medicare Services Ltd submitted its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI regulatory requirements.
Artemis Medicare received a Rs. 11.11 Crore Show Cause Notice from the GST department. The company is contesting this through a writ petition.
CARE Ratings reaffirmed Artemis Medicare's bank facility ratings at CARE A with Stable outlook. Long-term and short-term facilities totalling ₹388.15 Cr were reviewed.
Artemis reports strong Q1 FY27 growth, driven by Gurgaon performance and the Raipur hospital launch. Management is pivoting toward high-end quaternary care with a massive 2,000-bed expansion target by 2030.
Artemis Medicare Services will invest ₹180 Crore to add 200+ beds at its Gurugram hospital, focusing on pediatric and gynecological services.
Artemis Medicare Services filed its Monitoring Agency Report for the quarter ended June 30, 2026, regarding the utilization of proceeds from its past Preferential Issue.
Artemis Medicare Services reported Q1 FY27 consolidated revenue of ₹287.32 Crore, up 12.7% YoY. Operational milestones include the new Raipur hospital launch.
Artemis reports strong Q1 FY27 results with consolidated revenue up 12.7% YoY to INR 28,732 Lacs and PAT growing 48.3%. Growth is driven by core hospital operations and high-acuity clinical mix.
Artemis Medicare Services Ltd reported revenue from operations of ₹287.3 Cr (+12.7% YoY) and net profit of ₹31.4 Cr (+48.1% YoY) for Q1 FY27.
Artemis Medicare Services Ltd shareholders approved the appointment of Dr. Girdhar Jessaram Gyani as an Independent Director for a three-year term at its 22nd AGM.
Artemis Medicare Services Ltd held its 22nd Annual General Meeting on July 31, 2026, where shareholders considered various ordinary and special business items.
Artemis Medicare Services Ltd scheduled a board meeting for August 3, 2026. The board will consider the unaudited financial results for the quarter ended June 30, 2026.
Artemis Medicare Services Ltd announced voting results from a postal ballot. Shareholders approved a special resolution to raise funds via equity shares or other securities.
Artemis Medicare Services Ltd launched Artemis Shanti Hospital, a 300-bed multi‑specialty facility in Raipur, effective July 9 2026. The hospital expands the group's healthcare footprint in Central India.
Artemis Medicare filed its BRSR for FY 2025-26, detailing ESG performance and operations. The report covers 3 hospitals and 1,677 workers, with no financial or corporate action disclosed.
Artemis Medicare Services Ltd announces its 22nd AGM on July 31, 2026. Agenda includes adopting FY25-26 financials, declaring a Rs.0.45 dividend, and appointing directors.
Artemis Medicare Services approved raising up to ₹700 Crore through equity or other securities. The company will seek shareholder approval via postal ballot for this capital exercise.
Artemis Medicare Services scheduled a board meeting on June 4, 2026, to discuss a Rs. 700 Crore fund raise. The meeting focuses on approving the postal ballot notice.
Artemis Medicare submitted its Annual Secretarial Compliance Report for FY2026. The report confirms overall compliance with SEBI regulations, noting resolution of a minor prior reporting delay.
Artemis Medicare delivered strong FY26 results with consolidated revenue of ₹1,081 Cr, up 15.4% YoY. Strategy focuses on expanding bed capacity and high-end quaternary care.
Artemis Medicare delivered a solid FY26 with 15.4% revenue growth, driven by core specialties and improved case mix. Management is aggressively expanding bed capacity from 800 to 2,000 by 2029.
Artemis Medicare Services announced the tenure completion of Independent Director Sunil Tandon on May 9, 2026. This departure follows standard regulatory rotation and governance cycles.
Artemis Medicare Services submitted its Monitoring Agency Report for the quarter ended March 2026. The company utilized ₹136.89 Crore of its ₹330 Crore preferential issue proceeds.
Artemis Medicare Services appointed Mr. Tapan Mitra as an Independent Director for three years. He brings 40 years of HR leadership experience from Apollo Tyres.